Unicycive Therapeutics, Inc. (UNCY) Misses Q2 EPS by 9c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q2 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Deutsche Bank Downgrades Synaptics (SYNA) to Hold
• TEN Holdings prices $7.5 million common stock offering at $1 per share